By :- Team VOH
7 May 2024
Akums Drugs and Pharmaceuticals has responded to the urgent need for hypertension management with the introduction of Amlodipine, Telmisartan & Metoprolol (ER) film-coated tablets. These tablets, approved by the Drugs Controller General of India (DCGI), offer a significant advancement in cardiovascular care.
Hypertension, a prevalent health concern globally, poses significant risks of vascular diseases and associated complications. Akums' fixed-dose combination (FDC) medication integrates the therapeutic benefits of three established medications into a single tablet, providing a comprehensive approach to blood pressure control.
Each component of the FDC contributes to its efficacy in managing hypertension. Amlodipine induces vasodilation and reduces blood pressure by blocking calcium channels, while Telmisartan promotes blood vessel relaxation through angiotensin II receptor inhibition. Metoprolol (ER) complements these actions by reducing cardiac output through beta-adrenergic receptor inhibition.
The introduction of Amlodipine, Telmisartan & Metoprolol (ER) film-coated tablets addresses the need for improved treatment strategies for hypertension. By offering a convenient single-pill option, it aims to enhance patient adherence and long-term blood pressure control, ultimately improving patient outcomes and quality of life.
18 May 2024
18 May 2024
18 May 2024
18 May 2024
18 May 2024